Long-term safety and efficacy of highly purified cannabidiol for treatment refractory epilepsy.

导出 LinkOut

翻译打印收藏纠错

第一作者： Tyler E,Gaston

第一单位： Department of Neurology and the UAB Epilepsy Center, University of Alabama at Birmingham, Birmingham, AL, USA; Veteran's Administration Medical Center, Birmingham, AL, USA. Electronic address: tegaston@uabmc.edu.

作者： Tyler E,Gaston ^[1] ; Steve B,Ampah ^[2] ; E,Martina Bebin ^[3] ; Leslie P,Grayson ^[4] ; Gary R,Cutter ^[2] ; Kathleen,Hernando ^[3] ; Jerzy P,Szaflarski ^[3] ; UAB CBD Program

作者单位： Department of Neurology and the UAB Epilepsy Center, University of Alabama at Birmingham, Birmingham, AL, USA; Veteran's Administration Medical Center, Birmingham, AL, USA. Electronic address: tegaston@uabmc.edu. ^[1] Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, USA. ^[2] Department of Neurology and the UAB Epilepsy Center, University of Alabama at Birmingham, Birmingham, AL, USA. ^[3] Department of Neurology and the UAB Epilepsy Center, University of Alabama at Birmingham, Birmingham, AL, USA; Veteran's Administration Medical Center, Birmingham, AL, USA. ^[4]

关键词 Adverse effects profile Cannabidiol Longitudinal data Seizure frequency Treatment resistant epilepsy